Vu Quan Anhinsider trades

In SEC Form 4 filings, Vu Quan Anh is listed as Chief Financial Officer of Monopar Therapeutics (MNPR). Vu Quan Anh reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 2.

Companies and roles

Company	Role	Transactions	Last filed
MNPRMonopar Therapeutics	Chief Financial Officer	3	Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
MNPRMonopar Therapeutics	Sep 30	Oct 2	M	614	not reported	not reported	2,835	No	Form 4
MNPRMonopar Therapeutics	Sep 30	Oct 2	F	180	$79.67	$14,341	2,655	No	Form 4
MNPRMonopar Therapeutics	Sep 30	Oct 2	M · derivative	614	$0.00	$0	7,984	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.